Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review
AimsTo perform a systematic review assessing the clinical manifestations and outcomes of cardiorenal syndrome or the presence of both cardiac and renal complications in the 2019 coronavirus disease (COVID-19) patients.MethodsAll relevant studies about cardiorenal syndrome or both cardiac and renal c...
Main Authors: | Ling Lin, Yangqin Chen, Dongwan Han, Andrew Yang, Amanda Y. Wang, Wenjie Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.915533/full |
Similar Items
-
Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development
by: Marcela Sorelli Carneiro-Ramos, et al.
Published: (2022-05-01) -
Factors for the development and progression of cardiorenal complications in women
by: E N Chicherina, et al.
Published: (2013-06-01) -
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
by: Edmund Y. M. Chung, et al.
Published: (2022-05-01) -
Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension)
by: N A Mukhin, et al.
Published: (2008-08-01) -
Renal Assessment in Acute Cardiorenal Syndrome
by: Piotr Łagosz, et al.
Published: (2023-01-01)